- Previous Close
10.42 - Open
9.98 - Bid 9.77 x 100
- Ask 9.87 x 100
- Day's Range
9.81 - 10.37 - 52 Week Range
8.08 - 27.05 - Volume
12,376,168 - Avg. Volume
22,901,987 - Market Cap (intraday)
8.486B - Beta (5Y Monthly) 0.67
- PE Ratio (TTM)
-- - EPS (TTM)
-10.01 - Earnings Date Jan 9, 2025
- Forward Dividend & Yield 1.00 (9.60%)
- Ex-Dividend Date Nov 18, 2024
- 1y Target Est
10.60
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
www.walgreensbootsalliance.com193,000
Full Time Employees
August 31
Fiscal Year Ends
Sector
Industry
Recent News: WBA
View More
Related Videos: WBA
Performance Overview: WBA
Trailing total returns as of 12/11/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: WBA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: WBA
View MoreValuation Measures
Market Cap
7.65B
Enterprise Value
37.39B
Trailing P/E
--
Forward P/E
6.74
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.06
Price/Book (mrq)
0.86
Enterprise Value/Revenue
0.26
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-5.85%
Return on Assets (ttm)
0.59%
Return on Equity (ttm)
-75.97%
Revenue (ttm)
147.66B
Net Income Avi to Common (ttm)
-8.64B
Diluted EPS (ttm)
-10.01
Balance Sheet and Cash Flow
Total Cash (mrq)
3.11B
Total Debt/Equity (mrq)
277.90%
Levered Free Cash Flow (ttm)
2.73B
Research Analysis: WBA
View MoreCompany Insights: WBA
WBA does not have Company Insights
Research Reports: WBA
View MoreWalgreens: As Reported Talks of Private Equity Buyout Excite Investors, Shares Surge
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
RatingPrice TargetReducing FY25 estimate
Walgreens Boots Alliance Inc. based in Deerfield, Illinois, is a holding company created in December 2014 when Walgreen completed its purchase of privately held Alliance Boots. The company generated $148 billion in FY23 sales. After divesting its healthcare distribution business, WBA has presence in 8 countries. About 85% of revenue is from the United States. The company has 12,700 stores and healthcare including the Walgreen, Duane Reade and Boots names. WBA owns about 10% of Cencora. WBA's fiscal year ends on August 31. The company has a United States Retail Pharmacy unit, an International unit, and a U.S. Healthcare segment, which includes recent investments in VillageMD, CareCentrix and Shields Health Solutions.
RatingPrice TargetGood Morning. This is the Market Digest for Monday, November 11, 2024, with
Good Morning. This is the Market Digest for Monday, November 11, 2024, with analysis of the financial markets and comments on Arista Networks Inc., Gen Digital Inc., Hologic Inc., Regeneron Pharmaceuticals Inc., Expedia Group Inc., Freeport-McMoRan Inc., Marathon Oil Corp., Northrop Grumman Corp. and Walgreens Boots Alliance Inc.
Walgreens Earnings: Caps Off 2024 on Promising Note; Store Closure Update Excites Investors
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
RatingPrice Target
Top Analysts: WBA
View MoreOverall Score
Discover which analysts rank highest for WBA overall weighted by direction, price target, and price movement.
Learn MoreDirection Score
Discover which analysts rank highest on predicting the directional movement of WBA.
Learn MorePrice Score
Discover which analysts rank highest on predicting the price target of WBA.
Learn More